市場調査レポート

商品コード

1447742

消化管ステント市場の評価：製品・素材・用途・エンドユーザー・地域別の機会および予測 (2017～2031年)

Gastrointestinal Stent Market Assessment, By Product, By Material, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年03月11日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 225 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の消化管ステントの市場規模は、2023年の5億1,583万米ドルから、2024年から2031年の予測期間中は5.35%のCAGRで推移し、2031年には7億8,268万米ドルの規模に成長すると予測されています。

消化管ステント市場は、胃腸障害や消化器疾患の有病率の上昇、低侵襲外科手術への嗜好の高まりなどの原動力のもと、顕著な成長を記録すると予測されています。消化器疾患の有病率は、消化器疾患にかかるリスクの高い高齢者人口の増加や、加工食品を含む不健康な食品の多量摂取など、いくつかの要因によって上昇しています。胃腸障害はまた、食習慣の変化、ライフスタイルの変化、病原菌、加工食品や寿司などの生ものの摂取といった要因によっても増加しています。医療機器、特にステントの設計や素材における技術の進歩も、市場の成長をさらに促進しています。自己拡張型金属ステントなどの先端材料の使用により、最小外科手術用の消化管ステントの人気がさらに高まっています。一方で、高額な手術費用や新興国での償還の制限による経済的な問題が市場の成長を妨げています。医療機器の承認と開発に関する厳しい規制が主要企業の事業拡大を妨げることもあります。こうした課題にもかかわらず、市場は今後飛躍的に成長すると予想されています。

胃腸疾患の有病率の上昇

胃腸障害や消化器疾患の有病率は増加傾向にあり、ライフスタイルの変化が大きな要因となっています。この増加は、ペースの速いライフスタイル、食生活の乱れ、COVID-19の影響などによるストレスといった要因と関連しています。過敏性腸症候群 (IBS) 、胃食道逆流症 (GERD) 、大腸癌などの特定の疾患は、顕著に罹患率が増加しています。これらの疾患の管理には、バランスのとれた食事、定期的な運動、十分な睡眠などの生活習慣の改善が推奨されます。これらの疾患は時に消化管の閉塞につながり、ステントを用いて外科的に除去されます。消化管疾患の有病率の上昇に伴い、消化管ステントに対する需要が高まり、市場の成長が見込まれています。National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) によると、米国では約6,000万人から7,000万人が消化器系疾患に罹患しています。

低侵襲手術への嗜好の高まり

低侵襲性外科処置への嗜好の高まりが、消化管ステントの需要を牽引しています。低侵襲の消化管手術は、従来の開腹手術と比較して、その有効性、入院期間の短縮、術後死亡率の低下、回復の早さなどから好まれています。生分解性ステントや薬剤溶出性ステントの開発といった技術の開発や新興経済諸国における医療部門の成長が、低侵襲外科手術の人気をさらに高め、消化管ステント市場の拡大を後押ししています。

当レポートでは、世界の消化管ステントの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
製品別
- 胆管ステント
- 十二指腸ステント
- 結腸ステント
- 膵臓ステント
- 食道ステント
素材別
- 自己拡張型金属ステント
- プラスチックステント
用途別
- 胆道疾患
- 過敏性腸症候群
- 消化器癌
- 結腸直腸癌
- 胃癌
- 食道癌
- 膵臓癌
エンドユーザー別
- 病院・診療所
- 外来手術センター
地域別
- 北米
- 欧州
- 南米
- アジア太平洋
- 中東・アフリカ
企業別の市場シェア

第5章世界の消化管ステント市場の展望：地域別

北米
欧州
南米
アジア太平洋
中東・アフリカ

第6章市場マッピング

製品別
素材別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長阻害要因 (課題・抑制要因)

第9章規制の枠組みとイノベーション

臨床試験
特許の情勢
規制当局の承認
イノベーション/新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (主要企業)

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Boston Scientific Corporation
Olympus Corporation
Merit Medical Systems
Medtronic Plc
Terumo Corporation
Johnson & Johnson Services, Inc.,
M Inc.
Smith & Nephew
Medline Industries, Inc.
B. Braun Melsungen AG
Danaher Corporation

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 2.Global Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 3.Global Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 4.Global Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 5.Global Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 6.Global Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 7.Global Gastrointestinal Stent Market Share (%), By Region, 2017-2031F
Figure 8.North America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 9.North America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 10.North America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 11.North America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 12.North America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 13.North America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 14.North America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
Figure 15.United States Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 16.United States Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 17.United States Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 18.United States Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 19.United States Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 20.United States Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 21.Canada Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 22.Canada Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 23.Canada Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 24.Canada Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 25.Canada Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 26.Canada Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 27.Mexico Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 28.Mexico Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 29.Mexico Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 30.Mexico Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 31.Mexico Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 32.Mexico Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 33.Europe Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 34.Europe Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 35.Europe Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 36.Europe Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 37.Europe Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 38.Europe Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 39.Europe Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
Figure 40.Germany Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 41.Germany Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 42.Germany Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 43.Germany Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 44.Germany Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 45.Germany Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 46.France Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 47.France Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 48.France Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 49.France Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 50.France Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 51.France Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 52.Italy Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 53.Italy Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 54.Italy Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 55.Italy Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 56.Italy Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 57.Italy Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 58.United Kingdom Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 59.United Kingdom Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 60.United Kingdom Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 61.United Kingdom Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 62.United Kingdom Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 63.United Kingdom Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 64.Russia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 65.Russia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 66.Russia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 67.Russia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 68.Russia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 69.Russia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 70.Netherlands Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 71.Netherlands Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 72.Netherlands Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 73.Netherlands Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 74.Netherlands Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 75.Netherlands Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 76.Spain Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 77.Spain Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 78.Spain Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 79.Spain Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 80.Spain Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 81.Spain Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 82.Turkey Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 83.Turkey Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 84.Turkey Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 85.Turkey Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 86.Turkey Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 87.Turkey Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 88.Poland Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 89.Poland Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 90.Poland Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 91.Poland Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 92.Poland Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 93.Poland Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 94.South America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 95.South America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 96.South America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 97.South America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 98.South America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 99.South America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 100.South America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
Figure 101.Brazil Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 102.Brazil Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 103.Brazil Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 104.Brazil Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 105.Brazil Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 106.Brazil Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 107.Argentina Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 108.Argentina Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 109.Argentina Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 110.Argentina Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 111.Argentina Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 112.Argentina Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 113.Asia-Pacific Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 114.Asia-Pacific Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 115.Asia-Pacific Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 116.Asia-Pacific Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 117.Asia-Pacific Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 118.Asia-Pacific Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 119.Asia-Pacific Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
Figure 120.India Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 121.India Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 122.India Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 123.India Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 124.India Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 125.India Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 126.China Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 127.China Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 128.China Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 129.China Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 130.China Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 131.China Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 132.Japan Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 133.Japan Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 134.Japan Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 135.Japan Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 136.Japan Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 137.Japan Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 138.Australia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 139.Australia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 140.Australia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 141.Australia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 142.Australia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 143.Australia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 144.Vietnam Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 145.Vietnam Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 146.Vietnam Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 147.Vietnam Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 148.Vietnam Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 149.Vietnam Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 150.South Korea Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 151.South Korea Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 152.South Korea Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 153.South Korea Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 154.South Korea Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 155.South Korea Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 156.Indonesia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 157.Indonesia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 158.Indonesia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 159.Indonesia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 160.Indonesia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 161.Indonesia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 162.Philippines Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 163.Philippines Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 164.Philippines Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 165.Philippines Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 166.Philippines Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 167.Philippines Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 168.Middle East & Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 169.Middle East & Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 170.Middle East & Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 171.Middle East & Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 172.Middle East & Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 173.Middle East & Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 174.Middle East & Africa Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
Figure 175.Saudi Arabia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 176.Saudi Arabia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 177.Saudi Arabia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 178.Saudi Arabia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 179.Saudi Arabia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 180.Saudi Arabia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 181.UAE Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 182.UAE Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 183.UAE Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 184.UAE Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 185.UAE Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 186.UAE Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 187.South Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
Figure 188.South Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
Figure 189.South Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
Figure 190.South Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
Figure 191.South Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
Figure 192.South Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
Figure 193.By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 194.By Material Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 195.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Product Code: MX11149

Global gastrointestinal stent market is projected to witness a CAGR of 5.35% during the forecast period 2024-2031, growing from USD 515.83 million in 2023 to USD 782.68 million in 2031. The gastrointestinal stent market is anticipated to register notable growth under driving forces like the rising prevalence of gastrointestinal disorders and digestive diseases, and the increasing preference for minimally invasive surgical procedures. The prevalence of gastrointestinal disorders is rising due to several factors, such as the growing geriatric population, which is at high risk of catching digestive problems, and high intake of unhealthy food, including processed food. Gastrointestinal disorders are also increasing due to factors such as changing food habits, lifestyle changes, pathogens, and intake of processed food and raw meat, for example, sushi. Technological advancements in the design and material of medical devices, specifically stents, have further enhanced the market growth. The use of advanced materials, such as self-expanding metal stents, has further increased the popularity of gastrointestinal stents for minimally surgical procedures. However, affordability issues due to high procedure costs and limited reimbursement in developing countries hinder market growth. Stringent regulations for the approval and development of medical devices sometimes hinder the expansion of key players. Despite these challenges, the market is expected to grow exponentially in future years.

For instance, in October 2020, Olympus Corporation, which is a global technology leader in delivering innovative medical and surgical solutions announced the commercial launch of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS). The product is made by M.I. Tech and distribution is being taken care of by Olympus in the United States. The Through-the-Scope (TTS) esophageal stent helps achieve luminal patency in different clinical applications. It is designed to be used in the palliative treatment of trachea-esophageal fistula and esophageal stricture which are caused due to malignant tumors.

Rising Prevalence of Gastrointestinal Disorders

The prevalence of gastrointestinal disorders and digestive diseases is on the rise, with lifestyle changes being a significant contributing factor. This increase is associated with factors such as fast-paced lifestyles, poor dietary habits, and stress, including the impact of the COVID-19 pandemic. Specific conditions like irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and colorectal cancer are notably increasing in incidence. Lifestyle modifications such as maintaining a balanced diet, regular exercise, and adequate sleep are recommended to help manage these conditions. These conditions sometimes lead to blockage of the GI tract which is surgically removed using stents. With the rising gastrointestinal disease prevalence, the market is expected to expand under the growing demand for GI stents. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 60 to 70 million United States population is affected by digestive diseases.

As per Agappe Diagnostics, in India, about 18% of people reported having digestive problems in 2020. Men were slightly more likely to report these issues (18%) compared to women (17%). As men get older, the number of people reporting digestive problems increases significantly, especially in those aged 75 and above (20%). People with higher education levels had a lower chance of reporting digestive problems (men: 16%, women: 10%). Those who had never worked or were unemployed had a higher prevalence of digestive issues (19%). Adults with certain chronic conditions, such as stroke and arthritis, were also more likely to report digestive problems.

Increasing Preference for Minimally Invasive Surgical Procedures

The increasing preference for minimally invasive surgical procedures is driving the demand for gastrointestinal stents. Minimally invasive gastrointestinal surgeries are preferred due to their effectiveness, shorter hospital stays, lower postoperative mortality rates, and quicker recovery compared to traditional open surgeries. Advancements in technology, such as the development of biodegradable and drug-eluting stents, and the growing healthcare sector in emerging economies further contribute to the popularity of minimally invasive surgical procedures enhancing the expansion of the gastrointestinal stent market. Market players actively present innovative products for the market to expand. For instance, in May 2023, Olympus Corporation received FDA clearance for its innovative EVIS X1 endoscopy system. The system includes the GIF-1100 scope, which can be used in the upper digestive tract (esophagus, stomach, and duodenum), and the CF-HQ1100DL/I colonovideoscope, intended for use in the lower digestive tract (anus, rectum, sigmoid colon, colon, and ileocecal valve).

Dominance of Biliary Stent Segment

Biliary stents are frequently utilized in gastroenterology interventions. They are effective in treating jaundice caused by both benign and malignant conditions. These stents, made of plastic or metal, are inserted by specialists. The selection of stent material relies on the obstruction cause, with metal stents being more cost-effective for inoperable malignant cases. Manufacturers are also actively involved in innovation and product development to cater to the market requisite. For instance, in November 2021, Boston Scientific Corporation, a United States-based company, gained regulatory approval (FDA and CE mark) for its AdvanixTM Biliary Plastic Stents. These stents serve as medical devices to address benign biliary strictures, suspected or confirmed biliary malignancies (tumors), and biliary stone disease. Currently, healthcare providers in Europe and other international markets have access to these stents, and Boston Scientific intends to introduce them in the United States during the first quarter of 2022.

Self-Expandable Metal Stents is the Preferred Material

Self-expandable metal stents are commonly used in gastrointestinal stenting due to several advantages. They are small enough to be delivered through an endoscope, allowing for minimally invasive procedures. These can be coated with chemicals to prevent tumor ingrowth, making them suitable for treating defects in the GI tract caused by conditions like perforations. Compared to older plastic stents, self-expandable metal stents offer a convenient insertion technique, lower complication rates, and better compliance. These stents are designed to be permanent solutions, often used in advanced-stage cancers where surgical removal is not feasible. For instance, in May 2019, Olympus revealed two new HANAROSTENT (Self-Expanding Metal Stents) at the Digestive Disease Week (DDW) 2019 conference, expanding its EndoTherapy portfolio. These new stents are manufactured by M.I. Tech and exclusively distributed by Olympus in the U.S. after receiving the 510(K) clearance. The HANAROSTENT LowAx Colonic and Duodenal Uncovered Stents cater to advanced procedures and provide specialized stent options for colorectal conditions.

North America to be the Dominating Region

North America's advanced healthcare infrastructure, increased awareness of gastrointestinal health issues, and a growing elderly population contribute to its dominant position in the market. Factors such as a high incidence of gastrointestinal diseases, a favorable reimbursement scenario, and the presence of key market players contribute to its market dominance. FDA approvals and government support for medical device development further enhance the market growth. The major factor contributing to lead in North America is the high incidence of digestive diseases like inflammatory bowel diseases. For instance, as per an article published in Gastroenterology AGA in July 2023, inflammatory bowel disease is diagnosed in more than 0.7% of Americans while age and sex-standardized incidence of inflammatory bowel disease per 100,000 person per years was estimated to be 10.9.

Future Market Scenario (2024-2031F)

The evolution of gastrointestinal stents showcases a progressive approach towards addressing complex GI conditions through advanced design innovations. Current efforts are geared towards refining existing stent types, such as metal, plastic, and biodegradable options. One focus is on anti-migratory features that prevent stents from moving within the body, reducing potential complications. Additionally, drug-eluting stents are being developed to deliver medications directly to targeted regions, helping to combat tumor growth. Another exciting advancement is the combination of radioactive stents with brachytherapy, showing promise in extending patient survival rates. As these technologies progress, they aim to minimize complications and enhance patient outcomes associated with gastrointestinal stents. For instance, QualiMed Innovative Medizinprodukte GmbH's Biodegradable Balloon-Expandable Biliary Stent System is under clinical investigation and is anticipated to be completed in mid-2024.

Key Players Landscape and Outlook

Boston Scientific Corporation, Olympus Corporation, Merit Medical Systems, Medtronic Plc, Terumo Corporation, Johnson & Johnson Services, Inc., 3M Inc., are some of the renowned players of the gastrointestinal stent market. The market is dominated by large key players who are actively involved in the research and development of innovative products. The recent acquisition of Taewoong Medical has significantly increased the market share of Olympus Corporation. Despite the developments, there have been reports of cancellation of deals in the market.

In February 2023, Olympus Corporation, a medtech company, announced the acquisition of Taewoong Medical Co., a South Korean manufacturer of medical devices, particularly gastrointestinal metallic stents. This acquisition aims to enhance Olympus's GI EndoTherapy product portfolio, ultimately improving patient outcomes through comprehensive solutions. Taewoong will receive approximately USD 370 million in cash with USD 255.5 million paid at closing and up to USD 114.5 million based on achieving future milestones.

In May 2023, Boston Scientific canceled its planned USD 230 million acquisition of South Korean medical technology company M.I.Tech which was responsible for gastrointestinal and airway stents in Boston. The deal, which would have given Boston Scientific a 64% stake in M.I.Tech, was announced in June 2022. Boston Scientific cited regulatory obstacles as the reason for ending the acquisition. The original agreement involved Boston Scientific paying 14,500 won per M.I.Tech share, totaling 291.2 billion won. The acquisition was expected to close in the second half of 2022.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Gastrointestinal Stent Market Outlook, 2017-2031F

4.1.Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2.By Product
- 4.2.1.Biliary Stents
- 4.2.2.Duodenal Stents
- 4.2.3.Colonic Stents
- 4.2.4.Pancreatic Stents
- 4.2.5.Esophageal Stents
4.3.By Material
- 4.3.1.Self-Expanding Metal Stents
- 4.3.2.Plastic Stents
4.4.By Application
- 4.4.1.Biliary Diseases
- 4.4.2.Irritable Bowel Syndrome
- 4.4.3.Gastrointestinal Cancers
- 4.4.4.Colorectal Cancer
- 4.4.5.Stomach Cancer
- 4.4.6.Esophageal Cancer
- 4.4.7.Pancreatic Cancer
4.5.By End-user
- 4.5.1.Hospitals and Clinics
- 4.5.2.Ambulatory Surgical Centers
4.6.By Region
- 4.6.1.North America
- 4.6.2.Europe
- 4.6.3.Asia-Pacific
- 4.6.4.South America
- 4.6.5.Middle East and Africa
4.7.By Company Market Share (%), 2023

5.Global Gastrointestinal Stent Market Outlook, By Region, 2017-2031F

5.1.North America*
- 5.1.1.Market Size & Forecast
  - 5.1.1.1.By Value
  - 5.1.1.2.By Volume
- 5.1.2.By Product
  - 5.1.2.1.Biliary Stents
  - 5.1.2.2.Duodenal Stents
  - 5.1.2.3.Colonic Stents
  - 5.1.2.4.Pancreatic Stents
  - 5.1.2.5.Esophageal Stents
- 5.1.3.By Material
  - 5.1.3.1.Self-Expanding Metal Stents
  - 5.1.3.2.Plastic Stents
- 5.1.4.By Application
  - 5.1.4.1.Biliary Diseases
  - 5.1.4.2.Irritable Bowel Syndrome
  - 5.1.4.3.Gastrointestinal Cancers
  - 5.1.4.4.Colorectal Cancer
  - 5.1.4.5.Stomach Cancer
  - 5.1.4.6.Esophageal Cancer
  - 5.1.4.7.Pancreatic Cancer
- 5.1.5.By End-user
  - 5.1.5.1.Hospitals and Clinics
  - 5.1.5.2.Ambulatory Surgical Centers
- 5.1.6.United States*
  - 5.1.6.1.Market Size & Forecast
  - 5.1.6.1.1.By Value
  - 5.1.6.1.2.By Volume
  - 5.1.6.2.By Product
  - 5.1.6.2.1.Biliary Stents
  - 5.1.6.2.2.Duodenal Stents
  - 5.1.6.2.3.Colonic Stents
  - 5.1.6.2.4.Pancreatic Stents
  - 5.1.6.2.5.Esophageal Stents
  - 5.1.6.3.By Material
  - 5.1.6.3.1.Self-Expanding Metal Stents
  - 5.1.6.3.2.Plastic Stents
  - 5.1.6.4.By Application
  - 5.1.6.4.1.Biliary Diseases
  - 5.1.6.4.2.Irritable Bowel Syndrome
  - 5.1.6.4.3.Gastrointestinal Cancers
  - 5.1.6.4.4.Colorectal Cancer
  - 5.1.6.4.5.Stomach Cancer
  - 5.1.6.4.6.Esophageal Cancer
  - 5.1.6.4.7.Pancreatic Cancer
  - 5.1.6.5.By End-user
  - 5.1.6.5.1.Hospitals and Clinics
  - 5.1.6.5.2.Ambulatory Surgical Centers
- 5.1.7.Canada
- 5.1.8.Mexico

All segments will be provided for all regions and countries covered

5.2.Europe
- 5.2.1.Germany
- 5.2.2.France
- 5.2.3.Italy
- 5.2.4.United Kingdom
- 5.2.5.Russia
- 5.2.6.Netherlands
- 5.2.7.Spain
- 5.2.8.Turkey
- 5.2.9.Poland
5.3.Asia-Pacific
- 5.3.1.India
- 5.3.2.China
- 5.3.3.Japan
- 5.3.4.Australia
- 5.3.5.Vietnam
- 5.3.6.South Korea
- 5.3.7.Indonesia
- 5.3.8.Philippines
5.4.South America
- 5.4.1.Brazil
- 5.4.2.Argentina
5.5.Middle East & Africa
- 5.5.1.Saudi Arabia
- 5.5.2.UAE
- 5.5.3.South Africa

6.Market Mapping, 2023

6.1.By Product
6.2.By Material
6.3.By Application
6.4.By End-user
6.5.By Region

7.Macro Environment and Industry Structure

7.1.Demand Supply Analysis
7.2.Import Export Analysis
7.3.Value Chain Analysis
7.4.PESTEL Analysis
- 7.4.1.Political Factors
- 7.4.2.Economic System
- 7.4.3.Social Implications
- 7.4.4.Technological Advancements
- 7.4.5.Environmental Impacts
- 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5.Porter's Five Forces Analysis
- 7.5.1.Supplier Power
- 7.5.2.Buyer Power
- 7.5.3.Substitution Threat
- 7.5.4.Threat from New Entrant
- 7.5.5.Competitive Rivalry

8.Market Dynamics

8.1.Growth Drivers
8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

9.1.Clinical Trials
9.2.Patent Landscape
9.3.Regulatory Approvals
9.4.Innovations/Emerging Technologies

10.Key Players Landscape

10.1.Competition Matrix of Top Five Market Leaders
10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

13.1.Boston Scientific Corporation
- 13.1.1.Company Details
- 13.1.2.Key Management Personnel
- 13.1.3.Products & Services
- 13.1.4.Financials (As reported)
- 13.1.5.Key Market Focus & Geographical Presence
- 13.1.6.Recent Developments
13.2.Olympus Corporation
13.3.Merit Medical Systems
13.4.Medtronic Plc
13.5.Terumo Corporation
13.6.Johnson & Johnson Services, Inc.,
13.7.3M Inc.
13.8.Smith & Nephew
13.9.Medline Industries, Inc.
13.10.B. Braun Melsungen AG
13.11.Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

消化管ステント市場の評価：製品・素材・用途・エンドユーザー・地域別の機会および予測 (2017～2031年)

Gastrointestinal Stent Market Assessment, By Product, By Material, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の消化管ステント市場の展望

第5章世界の消化管ステント市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Gastrointestinal Stent Market Outlook, 2017-2031F

5.Global Gastrointestinal Stent Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

消化管ステント市場の評価：製品・素材・用途・エンドユーザー・地域別の機会および予測 (2017～2031年)

Gastrointestinal Stent Market Assessment, By Product, By Material, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の消化管ステント市場の展望

第5章 世界の消化管ステント市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Gastrointestinal Stent Market Outlook, 2017-2031F

5.Global Gastrointestinal Stent Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の消化管ステント市場の展望

第5章世界の消化管ステント市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項